Protara Therapeutics, Inc. (FRA:1KPA)
4.380
-0.100 (-2.23%)
At close: Dec 19, 2025
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of €241 million as of December 19, 2025. Its market cap has increased by 247.53% in one year.
Market Cap
241.00M
Enterprise Value
130.09M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.38
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from 155.77M to 241.00M, an increase of 54.71%. That is a compound annual growth rate of 7.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 241.00M | -1.57% |
| Dec 31, 2024 | 244.85M | 1,169.99% |
| Dec 29, 2023 | 19.28M | -31.77% |
| Dec 30, 2022 | 28.25M | -57.63% |
| Dec 31, 2021 | 66.69M | -69.95% |
| Dec 31, 2020 | 221.90M | 42.45% |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.93B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 130.04B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |